Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC

Conditions:   Bowen's Disease;   Cutaneous Squamous Cell Carcinoma in Situ Intervention:   Drug: STP705 Sponsors:   Sirnaomics;   Amarex Clinical Research Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials